APRE: Aprea Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Aprea Therapeutics Inc (APRE).
$17.88M Market Cap.
APRE Market Cap. (MRY)
APRE Shares Outstanding (MRY)
APRE Assets (MRY)
Total Assets
$23.98M
Total Liabilities
$4.67M
Total Investments
$0
APRE Income (MRY)
Revenue
$1.50M
Net Income
-$12.96M
Operating Expense
$15.82M
APRE Cash Flow (MRY)
CF Operations
-$13.56M
CF Investing
-$15.48K
CF Financing
$14.82M
APRE Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $23,979,493 (5.87%) | $22,650,174 (-24.89%) | $30,155,827 (-46.93%) | $56,823,463 (-38.77%) |
Assets Current | $23,576,139 (4.68%) | $22,521,095 (-25.31%) | $30,153,506 (-46.71%) | $56,584,410 (-38.77%) |
Assets Non-Current | $403,354 (212.49%) | $129,079 (5461.35%) | $2,321 (-99.03%) | $239,053 (-38.47%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $19,307,455 (13.88%) | $16,953,506 (-33.89%) | $25,643,678 (-48.20%) | $49,506,964 (-36.03%) |
Property Plant & Equipment Net | $81,522 (-7.74%) | $88,362 (3707.07%) | $2,321 (-98.89%) | $209,681 (-41.61%) |
Cash & Equivalents | $22,890,055 (5.74%) | $21,647,537 (-24.80%) | $28,786,647 (-45.76%) | $53,076,052 (-40.38%) |
Accumulated Other Comprehensive Income | -$10,627,379 (-0.15%) | -$10,611,273 (0.11%) | -$10,623,408 (-2.55%) | -$10,358,956 (-3.21%) |
Deferred Revenue | $0 (0%) | $528,974 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $1,352,240 (-19.05%) | $1,670,369 (98.20%) | $842,754 (-52.47%) | $1,773,032 (-60.63%) |
Accumulated Retained Earnings (Deficit) | -$321,041,872 (-4.21%) | -$308,083,161 (-4.86%) | -$293,796,405 (-62.20%) | -$181,134,378 (-25.78%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $0 (0%) | $0 (0%) | $190,471 (-43.17%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $190,471 (-25.69%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $4,672,038 (-17.99%) | $5,696,668 (26.25%) | $4,512,149 (-38.33%) | $7,316,499 (-52.52%) |
Liabilities Current | $3,360,975 (-23.36%) | $4,385,605 (37.00%) | $3,201,086 (-56.25%) | $7,316,499 (-52.28%) |
Liabilities Non-Current | $1,311,063 (0.00%) | $1,311,063 (0.00%) | $1,311,063 (0%) | $0 (0%) |
APRE Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $1,502,581 (157.63%) | $583,231 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $6,458,699 (-23.36%) | $8,427,703 (-59.81%) | $20,969,771 (54.75%) | $13,550,478 (-9.25%) |
Research & Development Expense | $9,363,537 (22.76%) | $7,627,491 (-53.50%) | $16,402,273 (-31.36%) | $23,895,875 (-36.92%) |
Operating Expenses | $15,822,236 (-1.45%) | $16,055,194 (-85.84%) | $113,392,228 (202.81%) | $37,446,353 (-29.09%) |
Interest Expense | -$1,289,144 (-5.31%) | -$1,224,133 (-172.84%) | -$448,667 (-27124.94%) | -$1,648 (99.26%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$12,958,711 (9.30%) | -$14,286,756 (87.32%) | -$112,662,027 (-203.45%) | -$37,127,303 (30.58%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$12,958,711 (9.30%) | -$14,286,756 (87.32%) | -$112,662,027 (-203.45%) | -$37,127,303 (30.58%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$12,958,711 (9.30%) | -$14,286,756 (87.32%) | -$112,662,027 (-203.45%) | -$37,127,303 (30.58%) |
Weighted Average Shares | $5,509,921 (52.31%) | $3,617,607 (118.32%) | $1,657,055 (55.69%) | $1,064,325 (0.72%) |
Weighted Average Shares Diluted | $5,509,921 (52.31%) | $3,617,607 (118.32%) | $1,657,055 (55.69%) | $1,064,325 (0.72%) |
Earning Before Interest & Taxes (EBIT) | -$14,247,855 (8.14%) | -$15,510,889 (86.29%) | -$113,110,694 (-204.64%) | -$37,128,951 (30.86%) |
Gross Profit | $1,502,581 (157.63%) | $583,231 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$14,319,655 (7.45%) | -$15,471,963 (86.36%) | -$113,392,228 (-202.81%) | -$37,446,353 (29.09%) |
APRE Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$15,478 (83.37%) | -$93,093 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow from Financing | $14,821,895 (188.36%) | $5,139,990 (652.59%) | $682,973 (-60.91%) | $1,747,012 (1057.35%) |
Net Cash Flow from Operations | -$13,556,718 (-11.32%) | -$12,177,608 (51.31%) | -$25,011,136 (33.63%) | -$37,686,179 (9.85%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $1,249,699 (117.53%) | -$7,130,711 (70.69%) | -$24,328,163 (32.31%) | -$35,939,167 (13.77%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$15,478 (83.37%) | -$93,093 (0%) | $0 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $14,821,895 (188.36%) | $5,139,990 (652.59%) | $682,973 (-60.91%) | $1,747,012 (1057.35%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$7,181 (14.50%) | -$8,399 (-121.67%) | $38,758 (1671.06%) | -$2,467 (-100.41%) |
Share Based Compensation | $489,436 (10.12%) | $444,459 (-97.38%) | $16,981,266 (117.33%) | $7,813,743 (56.81%) |
Depreciation Amortization & Accretion | $22,318 (216.48%) | $7,052 (-96.22%) | $186,445 (-31.37%) | $271,677 (18.32%) |
APRE Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% | - | - |
Profit Margin | -862.40% (64.79%) | -2449.60% | - | - |
EBITDA Margin | -946.70% (64.39%) | -2658.30% | - | - |
Return on Average Equity (ROAE) | -54.10% (17.53%) | -65.60% (91.25%) | -750.10% (-1077.55%) | -63.70% (-13.14%) |
Return on Average Assets (ROAA) | -45.50% (13.17%) | -52.40% (82.00%) | -291.10% (-432.18%) | -54.70% (-11.41%) |
Return on Sales (ROS) | -948.20% (64.35%) | -2659.50% | - | - |
Return on Invested Capital (ROIC) | 609.80% (31.45%) | 463.90% (-84.75%) | 3042.40% (472.31%) | 531.60% (7.44%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.4 (-17.65%) | -1.19 (-1126.80%) | -0.1 (94.11%) | -1.65 (15.33%) |
Price to Sales Ratio (P/S) | 12.06 (-58.62%) | 29.15 | - | - |
Price to Book Ratio (P/B) | 0.93 (-10.62%) | 1.04 (51.46%) | 0.68 (-45.02%) | 1.24 (-7.65%) |
Debt to Equity Ratio (D/E) | 0.24 (-27.98%) | 0.34 (90.91%) | 0.18 (18.92%) | 0.15 (-25.63%) |
Earnings Per Share (EPS) | -2.35 (40.51%) | -3.95 (94.19%) | -67.99 (-94.93%) | -34.88 (31.08%) |
Sales Per Share (SPS) | 0.27 (69.57%) | 0.16 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -2.46 (27.39%) | -3.39 (77.53%) | -15.09 (57.37%) | -35.41 (10.55%) |
Book Value Per Share (BVPS) | 3.5 (-25.22%) | 4.69 (-69.72%) | 15.47 (-66.73%) | 46.52 (-36.49%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.35 (-30.49%) | 6.26 (-65.60%) | 18.2 (-65.91%) | 53.39 (-39.21%) |
Enterprise Value Over EBIT (EV/EBIT) | 1 (0.00%) | 1 (0%) | 0 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.59 (17.03%) | 0.51 (268.61%) | 0.14 (1241.67%) | -0.01 (81.54%) |
Asset Turnover | 0.05 (152.38%) | 0.02 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 7.01 (36.61%) | 5.13 (-45.49%) | 9.42 (21.80%) | 7.73 (28.30%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$13,572,196 (-10.61%) | -$12,270,701 (50.94%) | -$25,011,136 (33.63%) | -$37,686,179 (9.90%) |
Enterprise Value (EV) | -$8,410,331 (-7.39%) | -$7,831,599 (49.34%) | -$15,459,774 (-3692.62%) | $430,320 (-87.60%) |
Earnings Before Tax (EBT) | -$12,958,711 (9.30%) | -$14,286,756 (87.32%) | -$112,662,027 (-203.45%) | -$37,127,303 (30.58%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$14,225,537 (8.25%) | -$15,503,837 (86.27%) | -$112,924,249 (-206.38%) | -$36,857,274 (31.07%) |
Invested Capital | -$2,271,537 (32.85%) | -$3,382,968 (-84.67%) | -$1,831,906 (45.78%) | -$3,378,617 (69.86%) |
Working Capital | $20,215,164 (11.47%) | $18,135,490 (-32.71%) | $26,952,420 (-45.29%) | $49,267,911 (-36.09%) |
Tangible Asset Value | $23,979,493 (5.87%) | $22,650,174 (-24.89%) | $30,155,827 (-46.93%) | $56,823,463 (-38.77%) |
Market Capitalization | $17,880,831 (1.81%) | $17,562,363 (0.11%) | $17,542,276 (-71.52%) | $61,604,952 (-40.90%) |
Average Equity | $23,934,409 (9.86%) | $21,785,892 (45.05%) | $15,019,976 (-74.22%) | $58,255,017 (-38.66%) |
Average Assets | $28,509,514 (4.51%) | $27,279,424 (-29.51%) | $38,699,644 (-42.93%) | $67,813,180 (-37.73%) |
Invested Capital Average | -$2,336,561 (30.12%) | -$3,343,676 (10.06%) | -$3,717,794 (46.77%) | -$6,984,502 (35.65%) |
Shares | 5,434,903 (45.45%) | 3,736,673 (41.01%) | 2,649,891 (146.90%) | 1,073,257 (1.31%) |
